Dermatology Drug Developer Hits Ch. 11 With Sale Plan
Dermatology treatment developer Timber Pharmaceuticals Inc. filed for Chapter 11 in Delaware bankruptcy court, saying it wants to sell its assets to a failed pre-bankruptcy merger partner....To view the full article, register now.
Already a subscriber? Click here to view full article